Cytarabine-induced pericarditis: A case report and review of the literature of the cardio-pulmonary complications of cytarabine therapy
- 28 February 1995
- journal article
- case report
- Published by Elsevier in Leukemia Research
- Vol. 19 (2) , 141-144
- https://doi.org/10.1016/0145-2126(94)00123-r
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Cytarabine and Cardiac FailureAmerican Journal of Hematology, 1992
- Pericarditis Associated with High-Dose Cytarabine Therapy for Acute Myeloblasts Leukemia: a Rare Complication of TherapyLeukemia & Lymphoma, 1992
- Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.Journal of Clinical Oncology, 1991
- Fatal pulmonary failure complicating high-dose cytosine arabinoside therapy in acute leukemiaCancer, 1990
- Clinical and Bacteriologic Observations of a Toxic Shock–like Syndrome Due toStreptococcus pyogenesNew England Journal of Medicine, 1987
- Subacute pulmonary failure complicating therapy with high-dose ara-C in acute leukemiaCancer, 1985
- Pericarditis induced by high-dose cytarabine therapyArchives of internal medicine (1960), 1984
- High Dose Cytosine Arabinoside in the Management of Refractory Acute LeukaemiaScandinavian Journal of Haematology, 1982
- Ara-C lung: Noncardiogenic pulmonary edema complicating cytosine arabinoside therapy of leukemiaThe American Journal of Medicine, 1981
- The cytosine arabinoside (Ara‐C) syndromeMedical and Pediatric Oncology, 1981